LNTH FY 2022 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$935M+119.9% YoY

Gross Profit

$582M62.2% margin

Operating Income

$36M3.9% margin

Net Income

$28M3.0% margin

EPS (Diluted)

$0.40

Cash Flow

Operating Cash Flow

$282M

Free Cash Flow

$263M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$874M

Stockholders' Equity

$447M

Cash & Equivalents

$416M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$935M	$425M	+119.9%
Gross Profit	$582M	$188M	+209.9%
Operating Income	$36M	-$61M	+159.5%
Net Income	$28M	-$71M	+139.4%